Is the association between insulin resistance and diabetogenic haematopoietically expressed homeobox (HHEX) polymorphism (rs1111875) affected by polycystic ovary syndrome status?
F. Ramezani Tehrani A , M. Zarkesh B , M. Tohidi C , F. Azizi D and A. Zadeh-Vakili B EA Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No. 24 Arabi Street – Yemen Street – Velenjak – Tehran, 1985717413, Islamic Republic of Iran.
B Cellular and Molecular Endocrine Research Center, Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No. 24 Arabi Street – Yemen Street – Velenjak – Tehran, 1985717413, Islamic Republic of Iran.
C Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No. 24 Arabi Street – Yemen Street – Velenjak – Tehran, 1985717413, Islamic Republic of Iran.
D Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No. 24 Arabi Street – Yemen Street – Velenjak – Tehran, 1985717413, Islamic Republic of Iran.
E Corresponding author. Email: azitavakili@endocrine.ac.ir
Reproduction, Fertility and Development 29(4) 670-678 https://doi.org/10.1071/RD15157
Submitted: 20 April 2015 Accepted: 29 September 2015 Published: 13 November 2015
Abstract
Polycystic ovary syndrome (PCOS) is frequently accompanied by insulin resistance (IR). The aim of the present study was to investigate whether the genetic association between insulin resistance and two single nucleotide polymorphisms (SNPs), namely rs7903146 (C/T) in transcription factor 7-like 2 (TCF7L2) and rs1111875 (A/G) in haematopoietically expressed homeobox (HHEX), is affected by PCOS status in Iranian women. The study participants consisted of 582 women with PCOS (cases) referred to the Reproductive Endocrinology Research Center and 504 subjects without PCOS (controls), randomly selected from the Tehran Lipid and Glucose Study. Cases and controls were further subdivided to two groups according to IR status: those with and without IR. IR was identified on the basis of homeostasis model assessment of insulin resistance (HOMA-IR) ≥2.63. The SNPs in TCF7L2 and HHEX were genotyped by polymerase chain reaction–restriction fragment length polymorphism. There were no significant differences in the distribution of genotypes and alleles between cases and controls (P < 0.05). Among cases, the prevalence of the CC, CT and TT genotypes was 37.8%, 46.3% and 15.9%, respectively, whereas the prevalence of the AA, AG and GG genotypes was 13.5%, 46.1% and 40.4%, respectively. In the control group, the prevalence of the CC, CT and TT genotypes was 32.2%, 53.9% and 13.9%, respectively, whereas the prevalence of the AA, AG and GG genotypes was 11.3%, 48.6% and 40.0%, respectively. After adjustment for age and body mass index, the probability of IR was decreased by 49% among carriers of the A allele in the control group (95% confidence interval 0.33–0.78; P = 0.002). The findings of the present study suggest that the association between IR and diabetogenic polymorphisms may be affected by PCOS status.
Additional keywords: diabetogenic polymorphism, transcription factor 7-like 2 (TCF7L2).
References
Alibegovic, A. C., Sonne, M. P., Højbjerre, L., Hansen, T., Pedersen, O., van Hall, G., Holst, J. J., Stallknecht, B., Dela, F., and Vaag, A. (2010). The T-allele of TCF7L2 rs7903146 associates with a reduced compensation of insulin secretion for insulin resistance induced by 9 days of bed rest. Diabetes 59, 836–843.| The T-allele of TCF7L2 rs7903146 associates with a reduced compensation of insulin secretion for insulin resistance induced by 9 days of bed rest.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXltFSmtr0%3D&md5=9480e21c4162caea0f32dd5288abace7CAS | 20107109PubMed |
Amir, A. L., Barua, M., McKnight, N. C., Cheng, S., Yuan, X., and Balk, S. P. (2003). A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. J. Biol. Chem. 278, 30 828–30 834.
| A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXmtFeqsbk%3D&md5=b1dff358979eb6bf86760ca6261f1697CAS |
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., and Escobar-Morreale, H. F. (2000). A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 85, 2434–2438.
| A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.Crossref | GoogleScholarGoogle Scholar | 10902790PubMed |
Barber, T. M., and Franks, S. (2012). The link between polycystic ovary syndrome and both Type 1 and Type 2 diabetes mellitus: what do we know today? Womens Health (Lond. Engl.) 8, 147–154.
| The link between polycystic ovary syndrome and both Type 1 and Type 2 diabetes mellitus: what do we know today?Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xjt1Wqs7k%3D&md5=87d690348c8e549d80f498540d8a7a08CAS | 22375718PubMed |
Barber, T. M., Bennett, A. J., Groves, C. J., Sovio, U., Ruokonen, A., Martikainen, H., Pouta, A., Hartikainen, A. L., Elliott, P., Wass, J. A., Järvelin, M. R., Zeggini, E., Franks, S., and McCarthy, M. I. (2007a). Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS. Diabetologia 50, 2318–2322.
| Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXhtFSlsLzN&md5=ae8444fa2cd2c94776e509361c526b80CAS | 17805508PubMed |
Barber, T. M., Bennett, A. J., Gloyn, A. L., Groves, C. J., Sovio, U., Ruokonen, A., Martikainen, H., Pouta, A., Taponen, S., Weedon, M. N., Hartikainen, A. L., Wass, J. A., Järvelin, M. R., Zeggini, E., Franks, S., and McCarthy, M. I. (2007b). Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels. Eur. J. Hum. Genet. 15, 679–684.
| Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXls1Kjt70%3D&md5=32ed39c02dacfe5c5d0faa4e321a0a81CAS | 17342155PubMed |
Ben-Salem, A., Ajina, M., Suissi, M., Daher, H. S., Almawi, W. Y., and Mahjoub, T. (2014). Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS). Gene 533, 554–557.
| Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS).Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXhs12lu77J&md5=8837af30b10d7614df1474d1915265aaCAS | 24157263PubMed |
Biyasheva, A., Legro, R. S., Dunaif, A., and Urbanek, M. (2009). Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J. Clin. Endocrinol. Metab. 94, 2617–2625.
| Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXosl2ksbs%3D&md5=326ae0bd8ffb72e29d9f4ef8c0390087CAS | 19351735PubMed |
Bort, R., Martinez-Barbera, J. P., Beddington, R. S., and Zaret, K. S. (2004). Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. Development 131, 797–806.
| Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXitVGiurk%3D&md5=361c34d49e218b916037437165d207faCAS | 14736744PubMed |
Burghen, G. A., Givens, J. R., and Kitabchi, A. E. (1980). Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50, 113–116.
| Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaL3c%2Fnt1eltA%3D%3D&md5=df7f174d5cd1c5ba20beb712b9cedd2dCAS | 7350174PubMed |
Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., Taylor, A., and Poulton, R. (2002). Role of genotype in the cycle of violence in maltreated children. Science 297, 851–854.
| Role of genotype in the cycle of violence in maltreated children.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD38XlvV2jsbg%3D&md5=3786af82a6388999a8e633ab71dcf1bdCAS | 12161658PubMed |
Christopoulos, P., Mastorakos, G., Gazouli, M., Panidis, D., Deligeoroglou, E., Katsikis, I., Papadias, K., Diamandi-Kandarakis, E., and Creatsas, G. (2008). Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome. Gynecol. Endocrinol. 24, 486–490.
| Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXht12ltLbM&md5=2c2a10fd98c10be0009225b2c1854f91CAS | 18958766PubMed |
Deligeoroglou, E., Kouskouti, C., and Christopoulos, P. (2009). The role of genes in the polycystic ovary syndrome: predisposition and mechanisms. Gynecol. Endocrinol. 25, 603–609.
| The role of genes in the polycystic ovary syndrome: predisposition and mechanisms.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXht1KisLjP&md5=08886b0e015bbf048957d86c2629e1e3CAS | 19591017PubMed |
Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, Novartis Institutes of BioMedical Research, Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I., Chen, H., Roix, J. J., et al. (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331–1336.
| Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.Crossref | GoogleScholarGoogle Scholar | 17463246PubMed |
Dunaif, A., and Finegood, D. T. (1996). Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81, 942–947.
| 1:CAS:528:DyaK28Xhs1agsro%3D&md5=efaea3addc30c5ef14f65eb7384b99d2CAS | 8772555PubMed |
Ewens, K. G., Jones, M. R., Ankener, W., Stewart, D. R., Urbanek, M., Dunaif, A., Legro, R. S., Chua, A., Azziz, R., Spielman, R. S., Goodarzi, M. O., and Strauss, J. F. (2011). FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One 6, e16390.
| FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhtlWltbk%3D&md5=301d79a21f0794e446aeda58043e4463CAS | 21283731PubMed |
Goodarzi, M. O. (2008). Looking for polycystic ovary syndrome genes: rational and best strategy. Semin. Reprod. Med. 26, 5–13.
| Looking for polycystic ovary syndrome genes: rational and best strategy.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXitFShurc%3D&md5=8a0d59589a21843607a8be3e2090ad35CAS | 18181077PubMed |
Grarup, N., Rose, C. S., Andersson, E. A., Andersen, G., Nielsen, A. L., Albrechtsen, A., Clausen, J. O., Rasmussen, S. S., Jørgensen, T., Sandbaek, A., Lauritzen, T., Schmitz, O., Hansen, T., and Pedersen, O. (2007). Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 56, 3105–3111.
| Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXhsValurjL&md5=9a58d343f722fb8607413dada626beb0CAS | 17827400PubMed |
Hatch, R., Rosenfield, R. L., Kim, M. H., and Tredway, D. (1981). Hirsutism: implications, etiology, and management. Am. J. Obstet. Gynecol. 140, 815–830.
| 1:STN:280:DyaL3M3ltlSjuw%3D%3D&md5=80d401762e299f42bb7c17541107ebc8CAS | 7258262PubMed |
Kim, J. J., Choi, Y. M., Cho, Y. M., Hong, M. A., Chae, S. J., Hwang, K. R., Hwang, S. S., Yoon, S. H., and Moon, S. Y. (2012). Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes. Clin. Endocrinol. (Oxf) 77, 439–445.
| Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtF2gt7jO&md5=f24dd48b7340216346691b0e82f35658CAS | 22443257PubMed |
Lawson, M. A., Jain, S., Sun, S., Patel, K., Malcolm, P. J., and Chang, R. J. (2008). Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women. J. Clin. Endocrinol. Metab. 93, 2089–2096.
| Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXntFamsbk%3D&md5=4e250306c13e6039a8c87fe217c263f6CAS | 18334581PubMed |
Legro, R. S., Kunselman, A. R., Dodson, W. C., and Dunaif, A. (1999). Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84, 165–169.
| 1:CAS:528:DyaK1MXmslWltA%3D%3D&md5=c3693b5d9c3c760a17dc9d9d95dddb13CAS | 9920077PubMed |
Li, X., Li, Y., Song, B., Guo, S., Chu, S., Jia, N., and Niu, W. (2012). Hematopoietically-expressed homeobox gene three widely-evaluated polymorphisms and risk for diabetes: a meta-analysis. PLoS One 7, e49917.
| Hematopoietically-expressed homeobox gene three widely-evaluated polymorphisms and risk for diabetes: a meta-analysis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhvVShsr3J&md5=d3ae85c48bfa2cc8725cfbc5c0fe65d8CAS | 23166797PubMed |
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., and Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
| Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaL2MXlslKnu7k%3D&md5=2fdc7554b09697ee9dd88828633db1adCAS | 3899825PubMed |
Mendoza, N. (2011). Common genetic aspects between polycystic ovary syndrome and diabetes mellitus. Curr. Diabetes Rev. 7, 377–391.
| Common genetic aspects between polycystic ovary syndrome and diabetes mellitus.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhtlChurfK&md5=6369ab49c10f2e7ab9da0dfe2baf0a11CAS | 21864293PubMed |
Messer, C., Boston, R., Leroith, D., Geer, E., Miller, J. D., Messer, M., and Futterweit, W. (2012). Pancreatic beta-cell dysfunction in polycystic ovary syndrome: the role of metformin. Endocr. Pract. 18, 685–693.
| Pancreatic beta-cell dysfunction in polycystic ovary syndrome: the role of metformin.Crossref | GoogleScholarGoogle Scholar | 22548946PubMed |
Morgan, C. L., Jenkins-Jones, S., Currie, C. J., and Rees, D. A. (2012). Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J. Clin. Endocrinol. Metab. 97, 3251–3260.
| Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xhtlymu7nM&md5=3e0eb7b8312f7e3d2c94cfb5b35d7b77CAS | 22767635PubMed |
Muniyappa, R., Lee, S., Chen, H., and Quon, M. J. (2008). Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am. J. Physiol. Endocrinol. Metab. 294, E15–E26.
| Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXhtVWrsro%3D&md5=b557e41ee543d67955033ee599ec3b38CAS | 17957034PubMed |
Ovalle, F., and Azziz, R. (2002). Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil. Steril. 77, 1095–1105.
| Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.Crossref | GoogleScholarGoogle Scholar | 12057712PubMed |
Rahmani, M., Earp, M. A., Ramezani Tehrani, F., Ataee, M., Wu, J., Treml, M., Nudischer, R., P-Behnami, S., ReproGen Consortium, Perry, J. R., Murabito, J. M., Azizi, F., and Brooks-Wilson, A. (2013). Shared genetic factors for age at natural menopause in Iranian and European women. Hum. Reprod. 28, 1987–1994.
| Shared genetic factors for age at natural menopause in Iranian and European women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXhtVCqu7zI&md5=943ce084b4f6b5cb232231939288e2a3CAS | 23592221PubMed |
Ramos, R. B., Wiltgen, D., and Spritzer, P. M. (2013). Polymorphisms of TCF7L2 gene in South Brazilian women with polycystic ovary syndrome: a cross-sectional study. Eur. J. Endocrinol. 169, 569–576.
| Polymorphisms of TCF7L2 gene in South Brazilian women with polycystic ovary syndrome: a cross-sectional study.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXhvFOrtb7K&md5=e18b113d3ebbf45a661ff780a1c62051CAS | 23935130PubMed |
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007). A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341–1345.
| A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXmtVyitrY%3D&md5=cb12c29db69a69a32ae2aba3e39ce2beCAS | 17463248PubMed |
Shokouhi, S., Delpisheh, A., Haghani, K., Mahdizadeh, M., and Bakhtiyari, S. (2014). Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group. Clin. Lab. 60, 1269–1276.
| 1:CAS:528:DC%2BC2cXhs1Gnt73L&md5=9dce1918f84347a0d4b3a6254cd09d56CAS | 25185411PubMed |
Shu, L., Sauter, N. S., Schulthess, F. T., Matveyenko, A. V., Oberholzer, J., and Maedler, K. (2008). Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57, 645–653.
| Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXjt1Chtbo%3D&md5=c594947afa1de5717468195f2da9e96dCAS | 18071026PubMed |
Shu, L., Matveyenko, A. V., Kerr-Conte, J., Cho, J. H., McIntosh, C. H., and Maedler, K. (2009). Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum. Mol. Genet. 18, 2388–2399.
| Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXnt1ehtL0%3D&md5=6582ad15b030161dff5af09c4fdab153CAS | 19386626PubMed |
Skrha, J., Haas, T., Sindelka, G., Prázný, M., Widimský, J., Cibula, D., and Svacina, S. (2004). Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. J. Clin. Endocrinol. Metab. 89, 135–141.
| Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXmvFertQ%3D%3D&md5=2b65ec70140abd1a73e673e7461a2c79CAS | 14715840PubMed |
Tabara, Y., Osawa, H., Kawamoto, R., Onuma, H., Shimizu, I., Miki, T., Kohara, K., and Makino, H. (2009). Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 58, 493–498.
| Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXhslertrk%3D&md5=6fa7df61049ada5212ed5727585794c1CAS | 19033397PubMed |
Tang, S. T., Wang, C. J., Tang, H. Q., Peng, W. J., Wang, Y. M., and Zhang, Q. (2012). Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis. Mol. Biol. Rep. 39, 9649–9660.
| Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xht1ynsbzM&md5=6be630d6140ddef9b3ec1471b13061d3CAS | 22729915PubMed |
Tehrani, F. R., Rashidi, H., and Azizi, F. (2011). The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reprod. Biol. Endocrinol. 9, 144.
| The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study.Crossref | GoogleScholarGoogle Scholar | 22044512PubMed |
van Vliet-Ostaptchouk, J. V., Onland-Moret, N. C., van Haeften, T. W., Franke, L., Elbers, C. C., Shiri-Sverdlov, R., van der Schouw, Y. T., Hofker, M. H., and Wijmenga, C. (2008). HHEX gene polymorphisms are associated with type 2 diabetes in the Dutch Breda cohort. Eur. J. Hum. Genet. 16, 652–656.
| HHEX gene polymorphisms are associated with type 2 diabetes in the Dutch Breda cohort.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXltFeitLs%3D&md5=e49570f08de4761eb3e041347c120210CAS | 18231124PubMed |
Villareal, D. T., Robertson, H., Bell, G. I., Patterson, B. W., Tran, H., Wice, B., and Polonsky, K. S. (2010). TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes 59, 479–485.
| TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhvVyru7Y%3D&md5=21b6192efd6ef1eea09be8d9ed700784CAS | 19934000PubMed |
Waaseth, M., Olsen, K. S., Rylander, C., Lund, E., and Dumeaux, V. (2011). Sex hormones and gene expression signatures in peripheral blood from postmenopausal women: the NOWAC postgenome study. BMC Med. Genomics 4, 29.
| Sex hormones and gene expression signatures in peripheral blood from postmenopausal women: the NOWAC postgenome study.Crossref | GoogleScholarGoogle Scholar | 21453500PubMed |
Wheeler, E., and Barroso, I. (2011). Genome-wide association studies and type 2 diabetes. Brief. Funct. Genomics 10, 52–60.
| Genome-wide association studies and type 2 diabetes.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXjvFejtLo%3D&md5=d083916e3e7080c9c62fa89c28465ea0CAS | 21436302PubMed |
Wojciechowski, P., Lipowska, A., Rys, P., Ewens, K. G., Franks, S., Tan, S., Lerchbaum, E., Vcelak, J., Attaoua, R., Straczkowski, M., et al. (2012). Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia 55, 2636–2645.
| Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC38fgsVKgsA%3D%3D&md5=be941ff2801037cec50244aa6530bfdcCAS | 22801903PubMed |
Xu, P., Che, Y., Cao, Y., Wu, X., Sun, H., Liang, F., Sun, J., Ke, L., Yi, L., Wang, Y., et al. (2010). Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome. J. Assist. Reprod. Genet. 27, 23–28.
| Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhtF2ns73F&md5=71b326064584f47a35701ff6c518c1c5CAS | 20041287PubMed |
Zadeh-Vakili, A., Tehrani, F. R., and Hosseinpanah, F. (2011). Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetol. Metab. Syndr. 3, 18.
| Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women.Crossref | GoogleScholarGoogle Scholar | 21831271PubMed |
Zawadski, J. K., and Dunaif, A. (1992). Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In ‘Polycystic Ovary Syndrome’. (Eds A. Dunaif, J. R. Givens, F. P. Haseltine, G. R. Merriam) pp. 377–384. (Blackwell Scientific Publications: Boston.)